Form 4: F5 CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

F5, Inc. President and CEO, Francois Locoh-Donou, sold 3,334 shares of common stock for $300 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Francois Locoh-Donou, President, CEO, and Director of F5, Inc. (FFIV), reported a transaction involving the company's common stock.
• On March 25, 2026, Mr. Locoh-Donou disposed of 3,334 shares of F5, Inc. common stock.
• The shares were sold at a price of $300 per share, totaling $1,000,200.
• This transaction was executed pursuant to a Rule 10b5-1 trading plan established on December 3, 2025.
• Following the transaction, Mr. Locoh-Donou directly beneficially owns 146,989 shares of common stock.
• Additionally, 42,000 shares are indirectly beneficially owned through a family trust for the benefit of his children, where his spouse serves as trustee.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, typical for executive financial planning and not indicative of company performance or future prospects.

Industry Context

StockSavvy.ai notes that insider sales executed under Rule 10b5-1 plans are a common practice for executives to manage personal finances, diversify holdings, and ensure compliance with insider trading regulations by pre-scheduling transactions. This type of disclosure is routine and generally does not indicate a change in the company's operational performance or strategic direction.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine personal financial transaction by an executive under a pre-arranged plan, not signaling a change in company fundamentals.

Key Dates

Recommendation

The sale of shares by the CEO is a routine transaction executed under a pre-arranged 10b5-1 trading plan, which is a common practice for executives to manage personal finances and diversify holdings. It does not inherently signal a change in the company's fundamentals or future prospects, thus a 'hold' recommendation is maintained.

Keywords

F5, FFIV, insider trading, Form 4, stock sale, CEO, 10b5-1 plan, beneficial ownership